- CWR searched every state with an active cannabis or hemp program this week, plus the FDA recall portal for CBD and hemp product actions.
- Two confirmed recalls this week: pesticide-contaminated cannabis flower in Colorado and a mislabeled medical cannabis tincture in Pennsylvania.
- Texas smokable hemp enforcement is in limbo until the April 23 court hearing. Ohio’s intoxicating hemp ban remains in effect.
Two real recalls this week, both with verified primary sources. One is a contamination issue with a banned pesticide. One is a labeling error that could cause patients to dose themselves at twice the strength they intended. Both have direct consumer action required if you have these products at home.
🔴 Colorado: Levels IV Inc. Flower (Bud, Shake, Trim)
Issued: April 14, 2026 · Agency: Colorado MED and CDPHE · Type: Voluntary · Risk: High — banned pesticide · Locations: Six dispensaries across Colorado
Colorado’s Marijuana Enforcement Division and the Colorado Department of Public Health and Environment issued a health and safety advisory on April 14 for regulated marijuana flower produced and sold by Levels IV Inc. The flower tested positive for chlorfenapyr, a pesticide banned from use on cannabis in Colorado. The contaminated batches initially passed laboratory testing but were flagged after additional testing during an investigation into laboratory concerns.
Two harvest batches are affected. The recalled flower was sold at six Colorado dispensaries between September 9, 2025, and March 26, 2026. This is the tenth cannabis recall in Colorado in 2026. Chlorfenapyr has now been linked to at least twelve Colorado marijuana safety advisories since June 2025.
What to check: All Levels IV packaging carries license number 403R-00235. The specific affected production batch numbers are listed on the MED advisory. If you have flower from Levels IV purchased at any Colorado dispensary between September 2025 and March 2026, check the label against the batch numbers on the MED advisory page.
What to do: Destroy the product or return it to the dispensary where you bought it. Do not consume it. If you have experienced adverse health effects, seek medical attention and report to the MED via the MED Reporting Form. Call Poison Control at 1-800-222-1222 if needed.
What chlorfenapyr does: It is an insecticide that kills mites and insects by disrupting energy production in cells. It is banned from use on food crops by the EPA because it is toxic to humans. If ingested, it can cause nausea, vomiting, abdominal pain, and abdominal distension depending on how much was consumed.
🟡 Pennsylvania: CannTech PA (AYR Wellness) Revel 1:1 THC:CBD Tincture 300mg
Announced: April 13, 2026 · Agency: PA Department of Health, Bureau of Medical Marijuana (coordination) · Type: Voluntary · Risk: Labeling inaccuracy — dosing error · Program: Pennsylvania Medical Cannabis
The issue is a labeling inaccuracy. The 30ml bottles are labeled as containing 300mg total cannabinoids at 10mg per 1ml. The actual cannabinoid content is 600mg total cannabinoids at 20mg per 1ml. A patient using the labeled dose of 1ml would receive double the THC and CBD they intended. This poses a direct risk of incorrect dosing for medical patients.
What to check: The recalled product is the Revel 1:1 THC:CBD Tincture 300mg, 30ml oral tincture. No other CannTech tinctures or products are included in this recall.
What to do: Stop using the product. Return any unused portion to the dispensary where you purchased it. Pennsylvania medical patients can find additional information in the official AYR Wellness recall announcement. If you have experienced unexpected or stronger-than-usual effects from this product, contact your physician.
⚠️ Texas: Smokable Hemp Enforcement: April 23 Hearing Today (Regulatory Update; Not a Product Recall)
Status as of April 20: TRO still in effect · Next action: April 23 injunction hearing · Agency: Texas DSHS · Court: Travis County District Court
The temporary restraining order blocking Texas DSHS’s smokable hemp ban is expiring this week. A Travis County court will hear evidence on April 23 on whether to issue a full temporary injunction extending the block while the case plays out. If the court does not grant the injunction, the DSHS ban on smokable hemp — which covers THCA flower, pre-rolls, and hemp concentrates — could go back into effect the same day.
CWR will cover the April 23 outcome in next Monday’s recap. If you are a Texas hemp worker or retailer, April 23 is the date to watch.
⚠️ Ohio: Intoxicating Hemp Ban Remains in Effect (Regulatory Update; Not a Product Recall)
Ohio Senate Bill 56’s ban on all intoxicating hemp products — including delta-8, THCA flower, and hemp-derived THC and CBD beverages — remains in effect statewide as of March 20, 2026. Two active legal challenges have not produced statewide relief. If you are purchasing or selling these products outside a licensed Ohio cannabis dispensary, they remain illegal under state law. Contact the Ohio Division of Cannabis Control at com.ohio.gov/divisions/cannabis-control to report violations.
Recalls still active from prior weeks
The following recalls from earlier in 2026 remain active. If you have these products, stop using them and return them to the dispensary where you bought them.
- Colorado: J&C Corp dba Juicy Concentrates (April 1, 2026): Concentrates and vaporizer products, chlorfenapyr and MGK-264, 53 dispensaries statewide. See Colorado MED advisory page.
- New York: Keystone State Testing New York (February 26, 2026): 54 adult-use product lots across multiple licensees; Aspergillus mold falsely reported as passing. See NY OCM current recalls.
- Minnesota: Tidal Wave vapes (Ocean Wholesale LLC) (March 18, 2026) and Beezwax vapes and prerolls (Kooka LLC) (March 12, 2026): Both distributed to hemp retailers statewide; undisclosed THC content. See Minnesota OCM recalls.
- Oklahoma: Greenleaf Labs mandatory recall (March 19, 2026): Products tested by Greenleaf Labs between April 2023 and July 2025; yeast and mold calculation errors across approximately 19,000 samples. See OMMA recalled products.
For any adverse health effects from any recalled product, call Poison Control at 1-800-222-1222, available 24 hours a day.
The bigger picture this week
Two weeks after Colorado’s tenth recall of 2026, chlorfenapyr has now been linked to at least twelve Colorado safety advisories since last June. The pattern is documented and ongoing. The MED warned cannabis businesses in January that it was aware of non-compliance with pesticide testing requirements and that contamination investigations were becoming more complex.
The advisories have kept coming anyway. That is not a testing system catching isolated mistakes. It is a system catching a systemic problem that the industry has not fixed.
The Pennsylvania recall is a different kind of failure. No contamination, no pesticide. A bottle that said one thing and contained something else. For a medical patient using a cannabis tincture to manage a condition – someone who is dosing carefully and trusting the label – getting twice the cannabinoid content without warning is not a minor inconvenience. Mislabeling is in the “low risk” category for the severity indicator, but for the patient holding that bottle, double-dosing is not low risk.
Know about a recall we missed? Contact CWR.
Sources: Colorado MED — Levels IV Inc. April 14 advisory · Westword — Colorado pesticide recall six stores · CBS Colorado — Levels IV recall detail · AYR Wellness IR — CannTech PA tincture recall · Houston Public Media — Texas hemp hearing April 23 · New York OCM current recalls · Oklahoma OMMA recalled products · Minnesota OCM recalls · FDA recall portal
States given the all-clear for April 7 to April 13 date range, with agencies verified: Alaska (AMCO), Arizona (ADHS), Arkansas (ABC Medical Marijuana), California (DCC), Colorado (MED), Connecticut (DCP), Delaware (OMC and DATE for hemp), Florida (OMMU), Georgia (GMCC), Hawaii (DOH), Illinois (IDFPR), Iowa (DHHS Medical Cannabidiol Program), Louisiana (LDH), Maine (OCP), Maryland (MCA), Massachusetts (CCC), Michigan (CRA), Minnesota (OCM), Mississippi (MSDH), Missouri (DCR), Montana (DOR Cannabis), Nevada (CCB), New Hampshire (DHHS), New Jersey (CRC), New Mexico (CCD), New York (OCM), North Dakota (HHS), Ohio (DCC — SB 56 update covered above; no product-specific recall this week), Oklahoma (OMMA), Oregon (OLCC), Pennsylvania (DOH — no public page), Rhode Island (OCR), South Dakota (DOR), Utah (DHHS Medical Cannabis), Vermont (CCB), Virginia (CCA for cannabis, VDACS for hemp), Washington (LCB — no public recall since 2023), Washington DC (ABCA), West Virginia (BPH). Hemp-only enforcement states with no new actions: Alabama, Indiana, Kansas, Kentucky, Nebraska, North Carolina, South Carolina, Tennessee, Wisconsin. Federal: FDA recall portal – CLEAR. FDA CBD memo issued April 1 (prior week) noted above.
